Evaluation of Follow-Up CT Scans in Patients with Severe Initial Pulmonary Involvement by COVID-19
Table 1
Details of demographic and clinical data of patients and differences between the two groups.
Variables
Patients
Complete resolution
With residual findings
P‐value
N = 50
N = 42
N = 8
Demographic data
Age
54.4 (14.2)
53.6 (14.6)
58.7 (10.9)
0.39
Gender
Male
36 (72%)
30 (71.4%)
6 (75%)
0.84
Female
14 (28%)
12 (28.6%)
2 (25%)
Clinical data
81.1 (8.2)
81.5 (8.0)
79.0 (9.7)
0.46
Underlying disease
32 (64%)
28 (66.7%)
4 (50%)
0.25
Laboratory findings
WBC
9.4 (3.8)
9.3 (3.5)
10.1 (3.1)
0.57
Lymphocyte
2.2 (2.6)
2.4 (2.7)
1.3 (1.1)
0.33
Hemoglobin
12.5 (2.5)
12.4 (2.6)
12.8 (1.6)
0.72
Platelet
176.0 (95.2)
166.8 (98.9)
229.6 (41.8)
0.11
ESR
63.9 (38.3)
63.1 (36.0)
68.4 (52.1)
0.74
CRP
119.9 (76.2)
113.4 (77.5)
155.4 (61.2)
0.18
Treatment
Antibiotic
24 (48)
21 (50)
3 (37.5)
0.52
Antiviral
32 (64)
24 (57.1)
8 (100)
0.02
Steroid pulse
9 (18)
5 (11.9)
4 (50)
0.01
IVIG
2 (4)
0 (0)
2 (25)
0.001
Mechanical ventilation
20 (40)
16 (38.1)
4 (50)
0.53
mean (standard deviation); all other variables were reported as N (%). WBC = white blood cell; ESR: erythrocyte sedimentation rate; CRP = C-reactive protein; IVIG: intravenous immunoglobulin.
